Clinical significance and future of the prognostic factors uPA and PAI-1 for nodal-negative invasive breast cancer

被引：0
|
作者：
Streckert, I [1 ]
Bonatz, G. [2 ]
Kucharski, K. [3 ]
Marek, W.
Streckert, H. J.
Phillipou, S.
机构：
[1] Augusta Krankenanstalten, Inst Pathol & Zytol, Inst Pathol, Bochum, Germany
[2] Augusta Krankenanstalten, Bochum, Germany
[3] Malteser Krankenhaus St Anna, Brustzentrum Duisburg, Duisburg, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2008年 / 68卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：304 / 304
页数：1
相关论文
共 50 条
  • [21] The determination of prognostic factors uPA and PAI 1 for risk evaluation in nodal negative breast cancer - experiences of NNBC 3-Europe study
    Kantelhardt, E.
    Thomssen, C.
    Vetter, M.
    Geurts-Moespot, A.
    Schmidt, M.
    Veyret, C.
    Meisner, C.
    von Minckwitz, G.
    Hanf, V
    Martin, P.
    Augustin, D.
    Schmitt, M.
    Sweep, F.
    Harbeck, N.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2009, 69 (08) : 748 - 748
  • [22] Circulating levels of uPA and PAI-1 in breast cancer patients
    Carney, W. P.
    Brown-Shimer, S.
    Hamer, P. J.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A131 - A131
  • [23] Prognostic factors uPA/PAI-1: measurement in core needle biopsies
    Vetter, M.
    Landstorfer, B.
    Lantzsch, T.
    Buchmann, J.
    Grosse, R.
    Ruschke, K.
    Holzhausen, H-J
    Thomssen, C.
    Kantelhardt, E-J
    CANCER RESEARCH, 2012, 72
  • [24] Prognostic value of UPA, PAI-1, and PAI-2 mRNA expression in primary breast cancer.
    Spyratos, F
    Bouchet, C
    Tozlu, S
    Labroquère, M
    Vignaud, S
    Becette, V
    Lidereau, R
    Bièche, I
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 262 - 262
  • [25] uPA and PAI-1: Clinically Validated Biomarkers in Breast Cancer
    Duffy, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 : 30 - 30
  • [26] PAI-1 polymorphism and expression of uPA, PAI-1 and COX-2 in breast cancer.
    Minisini, AM
    Di Loreto, C
    Pestrin, M
    Fabbro, D
    Cardellino, GG
    Russo, S
    Andreetta, C
    Damante, G
    Piga, A
    Puglisi, F
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 879S - 879S
  • [27] INTRA-MAMMARY LYMPHANGIOSIS CARCINOMATOSA IN NODAL-NEGATIVE BREAST-CANCER, IS IT OF PROGNOSTIC-SIGNIFICANCE
    MERLIN, C
    GLOOR, F
    HARDMEIER, T
    SENN, HJ
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1980, 110 (16) : 605 - 609
  • [28] Differential Prognostic Impact of uPA and PAI-1 in Colon and Rectal Cancer
    Langenskiold, Marcus
    Holmdahl, Lena
    Angenete, Eva
    Falk, Peter
    Nordgren, Svante
    Ivarsson, Marie-Louise
    TUMOR BIOLOGY, 2009, 30 (04) : 210 - 220
  • [29] HMGA2 with uPAI/PAI-1 as prognostic factors in node negative breast cancer patients
    Wischnewsky, M.
    Boecker, W.
    Meyer, A.
    Milde-Langosch, K.
    Bullerdiek, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S258 - S258
  • [30] Quantitative protein network monitoring for uPA and PAI-1 in breast cancer
    Malinowsky, K.
    Boellner, C.
    Berg, D.
    Walch, A.
    Schuster, T.
    Schmitt, M.
    Becker, K. -F.
    VIRCHOWS ARCHIV, 2010, 457 (02) : 172 - 172
12345